Richtlijn CVRM feb2013 - KNMP

Dobre 2007 Dobre D, De Jongste MJL, Lucas C, Cleuren G, van Veldhuisen DJ, Ranchor AV, Haaijer-Ruskamp F.
Effectiveness of beta-blocker therapy in daily practice patients with advanced chronic heart failure;
is there an efect-modification by age Br J Clin Pharmacol 2007; 63: 356-364.
Doll 1994
Drost 2010
Duggal 2010
Dulmen 2007
Eerenberg 2011
Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years’
observations on male British doctors. BMJ 1994; 309: 901-911.
Drost JT, Arpaci G, van Eyck J, Maas AHEM. Hoge bloeddruk in de zwangerschap. Belangrijke
voorspeller voor cardiovasculair risico. Hartbulletin 2010 (41): 47- 48.
Duggal JK, Singh M, Attri N, Singh PP, Ahmed N, Pahwa S, et al. Effect of niacin therapy on
cardiovascular outcomes in patients with coronary artery disease. Journal of Cardiovascular
Pharmacology and Therapeutics.2010;15(2):158-166.
Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to
medical treatment: a review of reviews. BMC Health Serv Res 2007; 7: 55-68.
Eerenberg ES, Kamphuisen PW, Sijpkens MK. Reversal rivaroxaban and dabigatran by
prothrombin complex concentrate: a randomize, placebo-controlled, crossover study in
healthy subjects. Circulation 2011; 124: 1573-79.
Einstein 2010 EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, et al. Oral
rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010 23; 363(26) : 2499-
510.
Elliott 1996
Ephor 2008
Ephor 2011
Eriksson 1998
Eriksson 2007a
Eriksson 2007b
Elliott P, Stamler J, Nichols R et al. Intersalt revisited: further analysis of 24 hour sodium
excretion and blood pressure within and across populations. Intersalt Cooperative Research
Group. Br Med J 1996; 312: 1249-1253.
Ephor advies “ACE-remmers bij kwetsbare ouderen”. Te raadplegen via
http://ephor.artsennet.nl/home.htm
Ephor advies “Bètablokkers bij kwetsbare ouderen”. Te raadplegen via
http://ephor.artsennet.nl/home.htm
Eriksson M, Hådell K, Holme I, Walldius G, Kjellström T. Compliance with and efficacy of
treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in
primary care. J Intern Med. 1998 May;243(5):373-80.
Eriksson BI, Dahl OE, Rosencher N, Kurt AA, van Dijk CN, Frostick SP et al. Dabigatran
etexilate versus enoxaparin for prevention of venous thromboembolism after Total hip
replacement: a radnomised, double-blind, non-inferiority trial. Lancet 2007; 370 99591): 949- 956.
Eriksson BI, Dahl OE, Rosencher N, Kurt AA, van Dijk CN, Frostick SP, et al. Oral dabigatran
etexilate vs. Subcutaneous enoxaparin for the prevention of venous thromboembolism after Total
knee replacement: the RE-MODEL randomized trial. J Thromb Haemost 2007; 5(11) : 2178-2185.
Eriksson 2011
Eriksson BI, Dahk OE, Huo MH, Kurth AA, Hantel S, hermansson K, et al. Oral dabigatran versus
enoxaparin for thromboprophylaxis after primary Total hip arthroplasty ( RE- NOVATE II). A
randomised, double blinded, non-inferiority trial. Thromb Haemost 2011; 105 (4): 721-729.
Eussen 2010 Eussen SRBM, vd Elst ME, Klungel OH, Rompelberg CJM, Garssen J, Oosterveld MH, de Boer A,
de Gier JJ en Bouvy ML. A Pharmaceutical Care Program to Improve Adherence to Statin
Therapy: A Randomized Controlled Trial. Ann of Pharmacotherapy 2010; 44: 1905-1913.
FLeg 2008 Fleg JL, Mete M, Howard BV, et al. Effect of statins alone versus statins plus ezetimibe on
carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics
Study) trial. J Am Coll Cardiol 2008;52:2198-205.
Fournier 2004 Fournier A, Messerli FH, Achard JM, Fernandez L. Cerebroprotection mediated by angiotensin
II: a hypothesis supported by recent randomized clinical trials. J Am Coll Cardiol.
2004;43:1343-7.
Fox 2003 Fox KM, et al. Efficacy of perindopril in reduction of cardiovascular events among patients
with stable coronary artery disease: randomized, double blind, placebo-controlled,
multicentre trial (the EUROPA study). Lancet 2003; 362: 782-788.
87
CONCEPT